# PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: RECRUITING · Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy · Condition: Prostate Cancer (Adenocarcinoma)

- Company: Affidea Nu-med Center of Oncological DIagnostics and Therapy
- Sector: Prostate Cancer (Adenocarcinoma)
- Primary source: https://clinicaltrials.gov/study/NCT07426055

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.